{"id":{"repo_id":"sdstate","oai_identifier":"oai:openprairie.sdstate.edu:etd-1908"},"canonical_url":"https://search.ndltd.org/etd/sdstate/oai:openprairie.sdstate.edu:etd-1908","repository":{"repo_id":"sdstate","name":"South Dakota State University","base_url":"https://openprairie.sdstate.edu/do/oai/"},"display":{"title":"Symptoms Reported by Menopausal Women Taking Synthetic Hormone Replacement Therapy or Bioidentical Progesterone","abstract":"There are more than 40 million women in the United States who are menopausal. The general age at which a woman reaches menopause is 50years. American women will now spend approximately one third of their lives in menopause due to a longer life expectancy (Li et al., 1996; Warren & Kulak, 1999). Many women may experience symptoms of declining ovarian function and seek medical assistance. Several therapies have been utilized to help alleviate menopausal symptoms. These include a variety of synthetic hormones, bioidentical hormones, herbal products, and homeopathic remedies. The purpose of this study was to compare menopausal symptoms reported by women taking synthetic hormone replacement therapy or bioidentical progesterone. Participants were asked to recall the symptoms they experienced before starting treatment and what symptoms they were currently encountering on hormone therapy. There was no statistically significant difference in symptoms between the two groups of women prior to starting hormone therapy. There was a significant difference between the two groups of women currently on hormone therapy in the vasomotor domain. There was no significant difference between the HRT and progesterone groups currently on hormone therapy in the psychosocial, physical, and sexual domains.","abstract_html":"There are more than 40 million women in the United States who are menopausal. The general age at which a woman reaches menopause is 50years. American women will now spend approximately one third of their lives in menopause due to a longer life expectancy (Li et al., 1996; Warren &amp; Kulak, 1999). Many women may experience symptoms of declining ovarian function and seek medical assistance. Several therapies have been utilized to help alleviate menopausal symptoms. These include a variety of synthetic hormones, bioidentical hormones, herbal products, and homeopathic remedies. The purpose of this study was to compare menopausal symptoms reported by women taking synthetic hormone replacement therapy or bioidentical progesterone. Participants were asked to recall the symptoms they experienced before starting treatment and what symptoms they were currently encountering on hormone therapy. There was no statistically significant difference in symptoms between the two groups of women prior to starting hormone therapy. There was a significant difference between the two groups of women currently on hormone therapy in the vasomotor domain. There was no significant difference between the HRT and progesterone groups currently on hormone therapy in the psychosocial, physical, and sexual domains.","abstract_has_math":false,"creators":["Aberle, Melissa M."],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis - University Access Only","degree_discipline":"Graduate Nursing","degree_department":null,"school":null,"contributors":["Kay Foland"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:04:04Z","subjects":["menopause hormone therapy","therapeautic use of progesterone","health aspects of hormone therapy","Nursing"],"languages":["en"],"rights":["Copyright © 2001 Kay Foland. All rights reserved"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://openprairie.sdstate.edu/etd/908","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://openprairie.sdstate.edu/etd/908","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://openprairie.sdstate.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Aopenprairie.sdstate.edu%3Aetd-1908","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kay Foland"]},{"key":"dc:creator","label":"Author","values":["Aberle, Melissa M."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2001-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Graduate Nursing"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - University Access Only"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["menopause hormone therapy","therapeautic use of progesterone","health aspects of hormone therapy","Nursing"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright © 2001 Kay Foland. All rights reserved"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://openprairie.sdstate.edu/etd/908"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["There are more than 40 million women in the United States who are menopausal. The general age at which a woman reaches menopause is 50years. American women will now spend approximately one third of their lives in menopause due to a longer life expectancy (Li et al., 1996; Warren & Kulak, 1999). Many women may experience symptoms of declining ovarian function and seek medical assistance. Several therapies have been utilized to help alleviate menopausal symptoms. These include a variety of synthetic hormones, bioidentical hormones, herbal products, and homeopathic remedies. The purpose of this study was to compare menopausal symptoms reported by women taking synthetic hormone replacement therapy or bioidentical progesterone. Participants were asked to recall the symptoms they experienced before starting treatment and what symptoms they were currently encountering on hormone therapy. There was no statistically significant difference in symptoms between the two groups of women prior to starting hormone therapy. There was a significant difference between the two groups of women currently on hormone therapy in the vasomotor domain. There was no significant difference between the HRT and progesterone groups currently on hormone therapy in the psychosocial, physical, and sexual domains."]},{"key":"dc:title","label":"Title","values":["Symptoms Reported by Menopausal Women Taking Synthetic Hormone Replacement Therapy or Bioidentical Progesterone"]}]}],"canonical_facts":{"dc:contributor":["Kay Foland"],"dc:creator":["Aberle, Melissa M."],"dc:date.created":["2001-01-01T08:00:00Z"],"dc:description.abstract":["There are more than 40 million women in the United States who are menopausal. The general age at which a woman reaches menopause is 50years. American women will now spend approximately one third of their lives in menopause due to a longer life expectancy (Li et al., 1996; Warren & Kulak, 1999). Many women may experience symptoms of declining ovarian function and seek medical assistance. Several therapies have been utilized to help alleviate menopausal symptoms. These include a variety of synthetic hormones, bioidentical hormones, herbal products, and homeopathic remedies. The purpose of this study was to compare menopausal symptoms reported by women taking synthetic hormone replacement therapy or bioidentical progesterone. Participants were asked to recall the symptoms they experienced before starting treatment and what symptoms they were currently encountering on hormone therapy. There was no statistically significant difference in symptoms between the two groups of women prior to starting hormone therapy. There was a significant difference between the two groups of women currently on hormone therapy in the vasomotor domain. There was no significant difference between the HRT and progesterone groups currently on hormone therapy in the psychosocial, physical, and sexual domains."],"dc:identifier":["https://openprairie.sdstate.edu/etd/908"],"dc:language":["en"],"dc:rights":["Copyright © 2001 Kay Foland. All rights reserved"],"dc:subject":["menopause hormone therapy","therapeautic use of progesterone","health aspects of hormone therapy","Nursing"],"dc:title":["Symptoms Reported by Menopausal Women Taking Synthetic Hormone Replacement Therapy or Bioidentical Progesterone"],"thesis:degree_discipline":["Graduate Nursing"],"thesis:degree_level":["Thesis - University Access Only"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T09:04:04Z"}